MediPharm Labs Corp. (T:LABS*CA)

Business Focus: Alternative Medicine

Sector:  Healthcare Industry:  Pharmaceuticals
 
Company Contact
Address: 151 John Street
BARRIE ON L4N 2L1
Tel: N/A
Website: https://www.medipharmlabs.com
IR: See website
<
Key People
Keith Strachan
President
David Pidduck
Chief Executive Officer, Director
Greg Hunter
Chief Financial Officer
Business Overview
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.
Financial Overview
For the fiscal year ended 31 December 2023, Medipharm Labs Corp revenues increased 49% to C$33.1M. Net loss decreased 56% to C$13.1M. Revenues reflect Products transferred at a point in time segment increase of 62% to C$32.2M, Canada segment increase of 57% to C$23.1M, Australia segment increase from C$2.6M to C$5.4M. Lower net loss reflects ECL (recovery) on receivables decrease from C$134K (expense) to C$1.9M (income).
Employees: 166 as of Dec 31, 2023
Reporting Currency: Canadian Dollars
Enterprise value: $16.73M as of Dec 31, 2023
Annual revenue (TTM): $33.06M as of Dec 31, 2023
EBITDA (TTM): -$17.42M as of Dec 31, 2023
Net annual income (TTM): -$13.08M as of Dec 31, 2023
Free cash flow (TTM): -$12.81M as of Dec 31, 2023
Net Debt Last Fiscal Year: N/A
Shares outstanding: 404,043,917 as of Mar 6, 2024
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.